DE60002570D1 - Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein - Google Patents

Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein

Info

Publication number
DE60002570D1
DE60002570D1 DE60002570T DE60002570T DE60002570D1 DE 60002570 D1 DE60002570 D1 DE 60002570D1 DE 60002570 T DE60002570 T DE 60002570T DE 60002570 T DE60002570 T DE 60002570T DE 60002570 D1 DE60002570 D1 DE 60002570D1
Authority
DE
Germany
Prior art keywords
acetylcystone
swallowable tablets
acetylcysteine
weight
tablets high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60002570T
Other languages
English (en)
Other versions
DE60002570T2 (de
Inventor
Franco Castegini
Alessandro Grassano
Riccardo Barina
Italo Zuliani
Giovanni Gurrieri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of DE60002570D1 publication Critical patent/DE60002570D1/de
Application granted granted Critical
Publication of DE60002570T2 publication Critical patent/DE60002570T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60002570T 1999-04-06 2000-03-21 Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein Expired - Lifetime DE60002570T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI000704A IT1311907B1 (it) 1999-04-06 1999-04-06 Compresse deglutibili ad alto contenuto di n-acetilcisteina.
ITMI990704 1999-04-06
PCT/EP2000/002464 WO2000059500A1 (en) 1999-04-06 2000-03-21 Swallowable tablets with high content of n-acetylcysteine

Publications (2)

Publication Number Publication Date
DE60002570D1 true DE60002570D1 (de) 2003-06-12
DE60002570T2 DE60002570T2 (de) 2004-02-26

Family

ID=11382595

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002570T Expired - Lifetime DE60002570T2 (de) 1999-04-06 2000-03-21 Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein

Country Status (15)

Country Link
EP (1) EP1165065B1 (de)
CN (1) CN1159004C (de)
AT (1) ATE239463T1 (de)
AU (1) AU4106800A (de)
BR (1) BR0008657A (de)
CA (1) CA2361843C (de)
CO (1) CO4970828A1 (de)
DE (1) DE60002570T2 (de)
DK (1) DK1165065T3 (de)
EA (1) EA003878B1 (de)
ES (1) ES2197087T3 (de)
HU (1) HU228823B1 (de)
IT (1) IT1311907B1 (de)
PT (1) PT1165065E (de)
WO (1) WO2000059500A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US7993578B2 (en) 2004-10-29 2011-08-09 Depuy Spine, Inc. Methods and kits for aseptic filling of products
US8513261B2 (en) * 2009-03-13 2013-08-20 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
JP2012533559A (ja) * 2009-07-15 2012-12-27 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アセトアミノフェンの治療効果を改善するためのｎ−アセチルシステイン組成物および方法
IT1399492B1 (it) * 2010-04-13 2013-04-19 Alpex Pharma Sa Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.
CN102028657B (zh) * 2010-12-02 2012-05-23 海南美兰史克制药有限公司 乙酰半胱氨酸脂质体固体制剂
CN102144978B (zh) * 2011-04-11 2013-03-13 南京正科制药有限公司 一种乙酰半胱氨酸颗粒及其制备工艺
CN102743369A (zh) * 2012-06-19 2012-10-24 苏州朗易生物医药研究有限公司 一种乙酰半胱氨酸的药物组合物及其制备方法
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina
CN104784116B (zh) * 2015-04-15 2017-05-24 武汉诺贝药业有限公司 一种n‑乙酰半胱氨酸口服制剂
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN110292569B (zh) * 2019-07-15 2021-11-02 广东人人康药业有限公司 一种乙酰半胱氨酸胶囊及其制备方法
CN112843008A (zh) * 2021-02-07 2021-05-28 广东赛康制药厂有限公司 一种乙酰半胱氨酸片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226696A (en) * 1987-11-02 1991-10-25 Merck & Co Inc Tablet composition comprising a phthalazine acetic acid derivative as the active ingredient present in from 83-88 wt%
DK0481294T4 (da) * 1990-10-19 2001-06-18 Spirig Ag Fast, hurtigt-opløseligt lægemiddelpræparat indeholdende N-acetylcystein
ZA963590B (en) * 1995-05-10 1996-11-19 Adcock Ingram Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
HU228823B1 (en) 2013-05-28
EA003878B1 (ru) 2003-10-30
DK1165065T3 (da) 2003-09-01
EP1165065B1 (de) 2003-05-07
ES2197087T3 (es) 2004-01-01
CA2361843C (en) 2008-10-14
BR0008657A (pt) 2001-12-18
CN1159004C (zh) 2004-07-28
HUP0200646A2 (hu) 2002-07-29
PT1165065E (pt) 2003-08-29
EP1165065A1 (de) 2002-01-02
AU4106800A (en) 2000-10-23
WO2000059500A1 (en) 2000-10-12
CO4970828A1 (es) 2000-11-07
ATE239463T1 (de) 2003-05-15
CA2361843A1 (en) 2000-10-12
ITMI990704A1 (it) 2000-10-06
DE60002570T2 (de) 2004-02-26
EA200100947A1 (ru) 2002-04-25
IT1311907B1 (it) 2002-03-20
CN1345236A (zh) 2002-04-17

Similar Documents

Publication Publication Date Title
DE60002570D1 (de) Schluckbare tabletten mit einem hohen gehalt an n-acetylcystein
LUC00155I1 (de)
GEP20063799B (en) Tropane derivatives useful in therapy
NO20062098L (no) Faststofftilstandmontelukast
ATE329579T1 (de) Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
BG104680A (en) Celecoxib compositions
ATE165830T1 (de) Dihydro pyrazolopyrrole
EA200300323A1 (ru) ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ)
NZ514574A (en) Novel method of treatment
MY119403A (en) Novel compounds with analgesic effect.
CA2239174A1 (en) Novel compounds with analgesic effect
MY136406A (en) High drug load tablet
EA200200119A1 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
GB8817015D0 (en) Method of treatment
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
ECSP003807A (es) Composiciones valdecoxib
DE69033970D1 (de) Huperzin a analoge verbindungen
DE60010316D1 (de) Magnesiumomeprazol
GB0212410D0 (en) Organic compounds
GB9619660D0 (en) Prevention of gastrointestinal damage
GB984517A (en) New derivatives of 5-amino-isoindoline
NZ309498A (en) 2-substituted benzyl-benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
DE60324944D1 (de) Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin-antibiotikum
UA4344U (uk) Спосіб лікування дітей з helicobacter pylori-асоційованим гастродуоденітом та хронічною рецидивуючою кандидо-герпетичною інфекцією

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ZAMBON S.P.A., BRESSO, IT